Real-time enrollment status for this t-cell acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:06 PM UTC
| NCT Number | NCT06561074 |
| Recruiting Status | Recruiting |
| Condition | T-cell Acute Lymphoblastic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 22 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | September 18, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT06561074 is currently recruiting participants. This phase2 study for t-cell acute lymphoblastic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06561074 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06561074 was last updated 3 weeks ago (September 18, 2026). HelloStudys verifies this status automatically.